Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Key Research and Development Program of the Ministry of Science and Technology (2022YFF1202901)
National Natural Science Foundation of China (82171404)
the Science and Technology Planning Project of Guangzhou City (2023A03J0181)
Fundamental Research Funds for the Central Universities (22yklj04)
the Natural Science Foundation of Guangdong Province of China (2023A1515011529)
the Research Funds of the State Key Laboratory of Ophthalmology (2024ZZ06)
- License Information
-
More Information
Article History
Received: 9 February 2026
Accepted: 7 July 2026
First Online: 5 August 2026
Declarations
Ethics approval and consent to participate: N/A.
Consent for publication: All authors have reviewed the final manuscript and consented to publication.
Competing interests: Xiaolai Zhou is an Editorial Board Member for Molecular Neurodegeneration Advances and was not involved in the editorial review or decisions regarding this manuscript.
